# Medtronic plc (MDT) · Edgar & Edgarette company card

> Medtronic (MDT) grew revenue 8.4% in FY2026 to $36.4 billion, operating margin 17.8% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 53.2% of assets, and dividend per share up 13 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1613103 · fiscal year ended 2026-04-24 · 5 audited years read · [page](https://www.pops4.com/boards/company/MDT) · [JSON](https://www.pops4.com/boards/company/MDT.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $36.4B |
| Revenue growth, 1 year | 8.4% |
| Revenue growth per year | 3.5% |
| Operating margin | 17.8% (prior year 17.8%) |
| Net margin | 13.3% |
| Operating cash flow | $7.3B |
| Capital spending | $1.9B |
| Free cash flow | $5.4B |
| Cash | $1.9B |
| Long-term debt | $26.2B |
| Total assets | $93.0B |
| Total equity | $49.5B |
| Equity ÷ assets | 53.2% |
| Return on equity | 9.8% |
| Dividend per share | $2.84 |
| Dividend years rising | 13 |

## Readings, computed from those figures

- Altman Z: 3.75 (safe zone)
- Piotroski F: 7 of 9 (solid)
- Beneish M: -2.58 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $36.4B (FY2026), total debt $26.2B. Experience: revenue up 8.4% on the year, up 3.5% a year over 4 years; operating margin 17.8%, up from 17.8%. Soundness: equity 53.2% of assets, return on equity 9.8%, payout 75.2% of profit, dividend per share up 13 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $35.1B and $40.3B next year (method v4.1: its own 5-year record of growth weighed at 57% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $33.0B to $42.6B. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin 17.8% against a 7.5% median; growth 8.4% against 8.3%.

Range logged 2026-09-26, receipt 162badd7acae5f53, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-10-19 ([filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026066291/0001628280-26-066291-index.htm))

## Recent filings

- 8-K · filed 2026-10-19 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026066291/0001628280-26-066291-index.htm)
- 8-K · filed 2026-09-17 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026062505/0001628280-26-062505-index.htm)
- 10-Q · filed 2026-09-03 · [filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm)
- 8-K · filed 2026-09-01 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/0001628280-26-059697-index.htm)
- DEF 14A · filed 2026-08-17 · [filing](https://www.sec.gov/Archives/edgar/data/1613103/000161310326000010/0001613103-26-000010-index.htm)
- 10-K · filed 2026-06-18 · [filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001613103.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1613103

## Cite

POPS4, Edgar & Edgarette: Medtronic plc (MDT) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/MDT. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.